17α-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome after dietary weight loss

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 556-560

  Jakubowicz, Daniela J ^a   Nestler, John E ^b  

^a Hospital de Clinicas Caracas   (Venezuela)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; GESTONORONE; LEUPRORELIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LOW CALORY DIET; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; WEIGHT REDUCTION;

17-ALPHA-HYDROXYPROGESTERONE; ADULT; ANDROGENS; BLOOD GLUCOSE; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN; LEUPROLIDE; LUTEINIZING HORMONE; OBESITY; POLYCYSTIC OVARY SYNDROME; WEIGHT LOSS;

EID: 0031027956     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.2.556     Document Type: Article

References (42)

1. Yen SSC. 1980 The polycystic ovary syndrome. Clin Endocrinol (Oxf). 12:177-208.
2. Chang RJ, Nakamura RM, Judd HL, Kaplan SA. 1983 Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 57:356-359.
3. Geffner ME, Kaplan SA, Bersch N, Golde DW, Landaw EM, Chang RZ. 1986 Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion. Fertil Steril. 45:327-333.
4. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. 1987 Characterization of groups of hyperandrogenemic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 65:499-507.
5. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1165-1174.
6. Dunaif A, Green G, Futterweit W, Dobrjansky A. 1990 Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 70:699-704.
7. Carmina E, Ditkoff EC, Malizia G, Vijod AG, Janni A, Lobo RA. 1992 Increased circulating levels of immunoreactive beta-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion. Am J Obstet Gynecol. 167:1819-1824.
8. Ciaraldi TP, el Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SSC. 1992 Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab. 75:577-583.
9. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. 1992 Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 41:1257-1266.
10. Rosenbaum D, Haber RS, Dunaif A. 1993 Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am J Physiol. 264:E197-E202.
11. Dunaif A, Xia J, Book CB, Schenker E, Tang Z. 1995 Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest. 96:801-810.
12. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS. 1995 Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest. 96:520-527.
13. Apter D, Butzow T, Laughlin GA, Yen SS. 1995 Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab. 80:2966-2973.
14. Nestler JE, Strauss III JF. 1991 Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinol Metab Clin North Am. 20:807-823.
15. Nestler JE. 1994 Role of obesity and insulin in the development of anovulation. In: Filicori M, Flamigni C, eds. Ovulation induction: basic science and clinical advances. Amsterdam: Elsevier; 103-114.
16. Barbieri RL, Makris A, Randall RW, Daniels G, Kristner RW, Ryan KJ. 1986 Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 62:904-910.
17. Nestler JE, Barlascini CO, Matt DW, et al. 1989 Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 68:1027-1032.
18. Nestler JE, Jakubowicz DJ. 1996 Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction in insulin secretion in women with polycystic ovary syndrome. N Engl J Med. 335:617-623.
19. Plymate SR, Matej LA, Jones RE, Friedl KE. 1988 Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 67:460-464.
20. Nestler JE, Powers LP, Matt DW, et al. 1991 A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 72:83-89.
21. Nestler JE. 1993 Editorial: Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? J Clin Endocrinol Metab. 76:273-274,
22. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. 1994 Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism. 43:647-654.
23. Kiddy DS, Hamilton Fairley D, Seppälä M, et al. 1989 Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-1. Clin Endocrinol (Oxf). 31:757-763.
24. Kiddy DS, Hamilton Fairley D, Bush A, et al. 1992 Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 36:105-111.
25. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 327:157-162.
26. Rosenfield RL, Barnes RB, Ehrmann DA. 1994 Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 79:1686-1692.
27. Luppa P, Muller B, Jacob K, et al. 1995 Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation: evidence for an altered corticoid excretion. J Clin. Endocrinol Metab. 80:280-288.
28. White D, Leigh A, Wilson C, Donaldson A, Franks S. 1995 Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 42:475-481.
29. Ibañez L, Potau N, Zampolli M, et al. 1994 Source localization of androgen excess in adolescent girls. J Clin Endocrinol Metab. 79:1778-1784.
30. Campbell PJ, Gerich JE. 1990 Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity. J Clin Endocrinol Metab. 70:1114-1118.
31. Tremblay A, Sauve L, Despres JP, Nadeau A, Theriault G, Bouchard C. 1989 Metabolic characteristics of postobese individuals. Int J Obes. 13:357-366.
32. Letiexhe MR, Scheen AJ, Gérard PL, Desaive C, Lefèbvre PJ. 1994 Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects. Int J Obes Relat Metab Disord. 18:295-300.
33. Letiexhe MR, Scheen AJ, Gérard PL, Desaive C, Lefèbvre PJ. 1995 Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women. J Clin Endocrinol Metab. 80:364-369.
34. Yeh HC, Futterweit W, Thornton JC. 1987 Polycystic ovarian disease: US features in 104 patients. Radiology. 163:111-116.
35. Nestler JE, Clore JN, Blackard WG. 1992 Effects of insulin on steroidogenesis in vivo. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Cambridge: Blackwell; 265-278.
36. Preziosi P, Barrett-Connor E, Papoz L, et al. 1993 Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the Telecom Study. J Clin Endocrinol Metab. 76:283-287.
37. Nestler JE. 1995 Are there sex-specific effects of insulin on human dehydroepiandrosterone metabolism? Semin Reprod Endocrinol. 13:282-287.
38. Kurzer MS, Calloway DH. 1986 Effects of energy deprivation on sex hormone patterns in healthy menstruating women. Am J Physiol. 251:E483-E488.
39. Beitins IZ, Barkan A, Klibanski A, et al. 1985 Hormonal responses to short term fasting in postmenopausal women. J Clin Endocrinol Metab. 60:1120-1126.
40. Jakubowicz DJ, Beer NA, Beer RM, Nestler JE. 1995 Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women. J Clin Endocrinol Metab. 80:3373-3376.
41. Leenen R, van der Kooy K, Seidell JC, Deurenberg P, Koppeschaar HP. 1994 Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab. 78:1515-1520.
42. Tegelman R, Lindeskog P, Carlström K, Pouserte Å, Blomstrand R. 1986 Peripheral hormone levels in healthy subjects during controlled fasting. Acta Endocrinol (Copenh). 113:457-462.